Can GLP-1 agonists support patients on antipsychotics? Amir Meftah, MD, and colleagues explore its use.
Amir Meftah, MD
Advertisement
Dr Meftah is a psychiatry resident physician at One Brooklyn Health.
Articles by Amir Meftah, MD
Amir Meftah, MD, discusses the possibility of GLP-1s for addressing metabolic issues associated with antipsychotics.
Advertisement
Latest Updated Articles
Poster at APA Annual Meeting Explores the Use of GLP-1 Agonists for Antipsychotic-Associated Metabolic IssuesPublished: May 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
2
Preliminary Report on Dangers of AI Chatbots
3
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
